ScholarIQanswers from OpenAlex & ORCID
Israel Lowy
ResearcherPublications, citations & collaboration network
Israel Lowy is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Israel Lowy have?
ScholarIQindexed works
Israel Lowy has 339 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Israel Lowy have?
ScholarIQcitation count
Israel Lowy has 23,971 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Israel Lowy?
ScholarIQh-index
Israel Lowy has an h-index of 58 in OpenAlex.
What is the i10-index of Israel Lowy?
ScholarIQi10-index
Israel Lowy has an i10-index of 113 in OpenAlex.
What is the ORCID of Israel Lowy?
ScholarIQorcid
The ORCID for Israel Lowy is on the source record.
What is the OpenAlex record for Israel Lowy?
ScholarIQopenalex
The OpenAlex for Israel Lowy is on the source record.
What are the most-cited papers on Israel Lowy?
ScholarIQmost cited works
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus, William H. Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M. Salay, Tracee L. McMiller, Marta M. Gilson, Changyu Wang, Mark Selby, Janis M. Taube, Robert A. Anders, Lieping Chen, Alan J. Korman, Drew M. Pardoll, Israel Lowy, Suzanne L. Topalian
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
Alexander Stratigos, Aleksandar Sekulić, Ketty Peris, Oliver Bechter, S. Prey, Martin Kaatz, Karl D. Lewis, Nicole Basset‐Séguin, Anne Lynn S. Chang, Stéphane Dalle, Almudena Fernández Orland, Lisa Licitra, Caroline Robert, Claas Ulrich, Axel Hauschild, Michael R. Migden, Reinhard Dummer, Siyu Li, Suk-Young Yoo, Kosalai Kal Mohan, Ebony Coates, Vladimir Janković, Nathalie Fiaschi, Emmanuel Chiebuka Okoye, Ioannis D. Bassukas, Carmen Loquai, Vincenzo De Giorgi, Zeynep Eroglu, Ralf Gutzmer, Jens Ulrich, Susana Puig, Frank Seebach, Gavin Thurston, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Timothy G. Bowler, Matthew G. Fury
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Thomas U. Marron, Maria Isabel Fiel, Pauline Hamon, Nathalie Fiaschi, Edward Kim, Stephen C. Ward, Zhen Zhao, Joel Kim, Paul Kennedy, Ganesh Gunasekaran, Parissa Tabrizian, Deborah B. Doroshow, Meredith Legg, Ashley Hammad, Assaf Magen, Alice O. Kamphorst, Muhammed Shareef, Namita Gupta, Raquel P. Deering, Wei Wang, Fang Wang, Pradeep Thanigaimani, Jayakumar Mani, Leanna Troncoso, Alexandra Tabachnikova, Christie Chang, Güray Aktürk, Mark Buckup, Steven Hamel, Giorgio Ioannou, C. Hennequin, Hajra Jamal, Haley E. Brown, Antoinette Bonaccorso, Daniel M. Labow, Umut Sarpel, Talia D. Rosenbloom, Max W. Sung, Baijun Kou, Siyu Li, Vladimir Janković, Nicola James, Sara Hamon, Hung Kam Cheung, Jennifer S. Sims, Elizabeth Miller, Nina Bhardwaj, Gavin Thurston, Israel Lowy, Sacha Gnjatic, Bachir Taouli, Myron Schwartz, Miriam Mérad